A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Clinical Therapeutics
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novo Nordisk
OpenAlex ID: W2139425593
